Quantifies the harm of the 2013 suspension (coverage fell from ~70% to under 1%, 0.3% in 2016) and documents the April 2022 nationwide resumption with free catch-up vaccination for women who missed the program during the suspension.
the vaccination rate, which fell to 0.3% among females in the target age group of 11-16 years in 2016, has gradually improved in recent years
Quantifies the harm of the 2013 suspension (coverage fell from ~70% to under 1%, 0.3% in 2016) and documents the April 2022 nationwide resumption with free catch-up vaccination for women who missed the program during the suspension.